4 filings
8-K
VIE
Viela Bio, Inc.
11 Dec 19
Viela Bio Announces Initiation of Phase 2b Trial of VIB4920 in Sjögren’s Syndrome
7:22am
8-K
VIE
Viela Bio, Inc.
14 Nov 19
Viela Bio Reports Third Quarter 2019 Financial Results and Business Highlights
4:05pm
8-K
VIE
Viela Bio, Inc.
9 Oct 19
Viela Bio Enters Strategic Collaboration with Mitsubishi Tanabe Pharma to Develop and Commercialize Inebilizumab for Autoimmune Diseases in Japan and Other Asia Regions
7:25am
8-K
VIE
Viela Bio, Inc.
7 Oct 19
Viela Bio Announces Closing of Initial Public Offering
5:00pm
- Prev
- 1
- Next